The results showed that, in tumor tissues, the proportions of total T cells (28.88% vs. 2.93% vs. 5.16%) and the CD4+ T cell (89.23% vs. 36.97% vs. 34.33%) subset were significantly higher in the F1/F3-treated mice group compared with both the PBS- and P3-treated mice (Figure 3A,B and Figure S11). The gene discussed is CD4; the disease is neoplasm.